Your fact-checks will appear here
Brazilian government agency
Lipoless is used as a weight‑loss product in several forms (dietary supplements, injectable solutions, and branded “Lipoless Advance” capsules) and public reporting shows a mixed evidence base: manufa...
Lipoless refers to an injectable drug whose active ingredient is tirzepatide (manufacturer site states this) and regulators in Brazil have cited Lipoless among products blocked from import in November...
Lipoless is presented by its maker as an injectable tirzepatide product for obesity and type 2 diabetes; manufacturer information and the product leaflet discuss contraindications and cautions but do ...
Lipoless is marketed in multiple forms: a prescription injectable whose active ingredient is tirzepatide (company site) and over‑the‑counter “Lipoless”/“NS Lipoless” supplements with herbal blends (ma...
Lipoless—marketed in Paraguay as an injectable tirzepatide product—acts like GLP‑1/GIP dual agonists and is indicated for obesity and type 2 diabetes . Manufacturer guidance warns alcohol can increase...
There is no evidence in the provided reporting that any national medicines regulator has formally approved GaraHerb as a drug or therapeutic product; the only direct source about the product is its co...